259 related articles for article (PubMed ID: 15901939)
1. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
Szoke E; Gerich JE
Compr Ther; 2005; 31(2):106-12. PubMed ID: 15901939
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance as the core defect in type 2 diabetes mellitus.
Goldstein BJ
Am J Cardiol; 2002 Sep; 90(5A):3G-10G. PubMed ID: 12231073
[TBL] [Abstract][Full Text] [Related]
3. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus.
Gerich JE
Mayo Clin Proc; 2003 Apr; 78(4):447-56. PubMed ID: 12683697
[TBL] [Abstract][Full Text] [Related]
4. [Etiology of and therapy for type-2 diabetes mellitus].
Kazuga M
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):527-31. PubMed ID: 15052815
[No Abstract] [Full Text] [Related]
5. Addressing the insulin secretion defect: a logical first-line approach.
Gerich JE
Metabolism; 2000 Oct; 49(10 Suppl 2):12-6. PubMed ID: 11078470
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.
Groop L
Int J Clin Pract Suppl; 2000 Oct; (113):3-13. PubMed ID: 11965829
[TBL] [Abstract][Full Text] [Related]
7. Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes.
Schofield CJ; Sutherland C
Diabet Med; 2012 Aug; 29(8):972-9. PubMed ID: 22443306
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of type 2 diabetes mellitus.
DeFronzo RA
Med Clin North Am; 2004 Jul; 88(4):787-835, ix. PubMed ID: 15308380
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes mellitus.
DeFronzo RA; Ferrannini E; Groop L; Henry RR; Herman WH; Holst JJ; Hu FB; Kahn CR; Raz I; Shulman GI; Simonson DC; Testa MA; Weiss R
Nat Rev Dis Primers; 2015 Jul; 1():15019. PubMed ID: 27189025
[TBL] [Abstract][Full Text] [Related]
10. [Insulin resistance and pathogenesis of non-insulin-dependent diabetes mellitus (part II)].
Martinka E; Galajda P; Mokán M
Vnitr Lek; 1996 Mar; 42(3):200-4. PubMed ID: 8686211
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of type 2 diabetes and its relationship to new therapeutic approaches.
Bell D
Diabetes Educ; 2000; 26 Suppl():4-7. PubMed ID: 11912815
[No Abstract] [Full Text] [Related]
12. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
Evans AJ; Krentz AJ
Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
[No Abstract] [Full Text] [Related]
13. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and treatment of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM).
Gerich JE
Horm Metab Res; 1996 Sep; 28(9):404-12. PubMed ID: 8911974
[TBL] [Abstract][Full Text] [Related]
15. Potential new treatments for type 2 diabetes.
Bailey CJ
Trends Pharmacol Sci; 2000 Jul; 21(7):259-65. PubMed ID: 10871894
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of type 2 diabetes mellitus.
Dostou J; Gerich J
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S149-56. PubMed ID: 11460566
[TBL] [Abstract][Full Text] [Related]
17. [Type 2 diabetes mellitus].
Kashiwagi A
Nihon Rinsho; 2006 Sep; Suppl 3():42-8. PubMed ID: 17022497
[No Abstract] [Full Text] [Related]
18. [Molecular mechanism and clinical impact of insulin resistance in type 2 diabetes mellitus].
Maegawa H; Kashiwagi A
Nihon Rinsho; 1999 Mar; 57(3):539-44. PubMed ID: 10199130
[TBL] [Abstract][Full Text] [Related]
19. [Etiopathogenesis and pathophysiology of type 2 diabetes].
Féry F; Paquot N
Rev Med Liege; 2005; 60(5-6):361-8. PubMed ID: 16035295
[TBL] [Abstract][Full Text] [Related]
20. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.
Porte D
Diabetes Metab Res Rev; 2001; 17(3):181-8. PubMed ID: 11424231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
